Carmen Mestre‐Durán

Author

Carmen Mestre‐Durán

Hospital La Paz Institute for Health Research ORCID

Also Known As

C Mestre-Durán, C. Mestre, C. Mestre-Duran, C. Mestre-Durán, Carmen Mestre, Carmen Mestre-Duran, Carmen Mestre-Durán, Carmen Mestre‐Durán, Mestre-Duran, Carmen

Publications

269

Citations

H-Index

Concepts

All Affiliations

Hospital La Paz Institute for Health Research Hospital Universitario La Paz Universidad Autónoma de Madrid Spanish National Cancer Research Centre Research Institute Hospital 12 de Octubre

About

Carmen Mestre‐Durán is an author at Hospital La Paz Institute for Health Research specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	45
2	Health Sciences	1	1	27
3	Blood Transplantation	1	1	27
4	Cell Biology	1	1	18
5	Cellular Therapies	1	1	18

Carmen Mestre‐Durán

Publications

231

Citations

H-Index

Page 1

	Year	Citations
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy Cristina Ferreras, B. Pascual-Miguel, Carmen Mestre‐Durán, Frontiers in Cell and Developmental Biology	2021	51
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE) Antonio Pérez‐Martínez, Marta Mora-Rillo, Cristina Ferreras, EClinicalMedicine	2021	36
Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy Adrián Fernández, Alfonso Navarro‐Zapata, Adela Escudero, Cancers	2021	30
Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity Yasmina Mozo, David Bueno, Luisa Sisinni, Pediatric Hematology and Oncology Transplantation MedicineImmunologyPathologyCell Replacement TherapyPediatric Hsct	2021	27
Anti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma Immunotherapy María Vela, David Bueno, Pablo González‐Navarro, Frontiers in Immunology	2019	27
Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL–Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia Lara M. Gómez García, Adela Escudero, Carmen Mestre‐Durán, Clinical Lymphoma Myeloma & Leukemia Hematological MalignancyCell TherapyCellular TherapiesImmunologyHematology	2021	18
NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells Marta Ibáñez-Navarro, Adrián Fernández, Adela Escudero, Frontiers in Immunology	2023	18
Familial CD45RA– T cells to treat severe refractory infections in immunocompromised patients Karima Al‐Akioui‐Sanz, Carlos Echecopar, Cristina Ferreras, Frontiers in Medicine	2023	13
Inherited human ezrin deficiency impairs adaptive immunity Blanca García‐Solis, Ana Van Den Rym, Laura Martínez‐Martínez, Journal of Allergy and Clinical Immunology	2023	11

Page 1